News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
638,397 Results
Type
Article (47899)
Company Profile (218)
Press Release (590257)
Multimedia
Podcasts (108)
Webinars (21)
Section
Business (171784)
Career Advice (2520)
Deals (31694)
Drug Delivery (134)
Drug Development (76543)
Employer Resources (140)
FDA (16727)
Job Trends (13566)
News (304553)
Policy (30745)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (2578)
Academic (1)
Accelerated approval (46)
Adcomms (30)
Allergies (164)
Alliances (45993)
ALS (193)
Alzheimer's disease (1740)
Antibody-drug conjugate (ADC) (383)
Approvals (17035)
Artificial intelligence (618)
Autoimmune disease (239)
Automation (48)
Bankruptcy (343)
Best Places to Work (10912)
BIOSECURE Act (22)
Biosimilars (208)
Biotechnology (156)
Bladder cancer (173)
Brain cancer (69)
Breast cancer (675)
Cancer (5377)
Cardiovascular disease (457)
Career advice (2133)
Career pathing (42)
CAR-T (306)
CDC (60)
Celiac Disease (2)
Cell therapy (826)
Cervical cancer (39)
Clinical research (66510)
Collaboration (1964)
Company closure (5)
Compensation (866)
Complete response letters (87)
COVID-19 (2532)
CRISPR (103)
C-suite (1041)
Cystic fibrosis (150)
Data (7027)
Decentralized trials (2)
Denatured (37)
Depression (161)
Dermatology (67)
Diabetes (552)
Diagnostics (6281)
Digital health (47)
Diversity (11)
Diversity, equity & inclusion (34)
Drug discovery (322)
Drug pricing (201)
Drug shortages (33)
Duchenne muscular dystrophy (270)
Earnings (68513)
Editorial (70)
Employer branding (16)
Employer resources (130)
Events (88082)
Executive appointments (1059)
FDA (20282)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (32)
Funding (1679)
Gene editing (219)
Generative AI (61)
Gene therapy (693)
GLP-1 (1058)
Government (4231)
Grass and pollen (7)
Guidances (395)
Healthcare (17408)
HIV (79)
Huntington's disease (48)
IgA nephropathy (91)
Immunology and inflammation (259)
Immuno-oncology (90)
Indications (161)
Infectious disease (2857)
Inflammatory bowel disease (208)
Inflation Reduction Act (11)
Influenza (127)
Intellectual property (278)
Interviews (479)
IPO (14884)
IRA (49)
Job creations (3050)
Job search strategy (1728)
JPM (66)
Kidney cancer (19)
Labor market (70)
Layoffs (469)
Leadership (42)
Legal (6748)
Liver cancer (99)
Longevity (23)
Lung cancer (711)
Lymphoma (404)
Machine learning (56)
Management (49)
Manufacturing (926)
MASH (180)
Medical device (11985)
Medtech (12054)
Mergers & acquisitions (17932)
Metabolic disorders (1437)
mRNA (185)
Multiple sclerosis (184)
NASH (20)
Neurodegenerative disease (396)
Neuropsychiatric disorders (96)
Neuroscience (3168)
Neurotech (1)
NextGen: Class of 2026 (6073)
Non-profit (4334)
Now hiring (40)
Obesity (677)
Opinion (323)
Ovarian cancer (189)
Pain (242)
Pancreatic cancer (263)
Parkinson's disease (354)
Partnered (34)
Patents (561)
Patient recruitment (629)
Peanut (59)
People (53477)
Pharmaceutical (51)
Pharmacy benefit managers (29)
Phase 1 (20501)
Phase 2 (29158)
Phase 3 (22156)
Pipeline (7341)
Policy (317)
Postmarket research (2374)
Preclinical (8599)
Press Release (53)
Prostate cancer (277)
Psychedelics (48)
Radiopharmaceuticals (316)
Rare diseases (1038)
Real estate (4810)
Recruiting (65)
Regulatory (24877)
Reports (35)
Research institute (2381)
Resumes & cover letters (420)
Rett syndrome (33)
RNA editing (22)
RSV (85)
Schizophrenia (163)
Series A (285)
Series B (208)
Service/supplier (3)
Sickle cell disease (103)
Special edition (23)
Spinal muscular atrophy (170)
Sponsored (45)
Startups (3707)
State (2)
Stomach cancer (17)
Supply chain (118)
Tariffs (80)
The Weekly (68)
Vaccines (1043)
Venture capital (110)
Weight loss (452)
Women's health (111)
Worklife (18)
Date
Today (1)
Last 7 days (565)
Last 30 days (2342)
Last 365 days (28693)
2026 (8674)
2025 (28772)
2024 (32895)
2023 (36887)
2022 (47491)
2021 (51333)
2020 (49828)
2019 (42850)
2018 (32494)
2017 (30047)
2016 (28582)
2015 (32925)
2014 (25552)
2013 (21678)
2012 (23015)
2011 (23671)
2010 (22067)
Location
Africa (838)
Alabama (87)
Alaska (6)
Arizona (248)
Arkansas (15)
Asia (39436)
Australia (6498)
California (11165)
Canada (3425)
China (1247)
Colorado (499)
Connecticut (498)
Delaware (367)
Europe (87493)
Florida (1776)
Georgia (358)
Hawaii (3)
Idaho (52)
Illinois (940)
India (81)
Indiana (556)
Iowa (20)
Japan (494)
Kansas (121)
Kentucky (36)
Louisiana (38)
Maine (86)
Maryland (1363)
Massachusetts (8182)
Michigan (326)
Minnesota (561)
Mississippi (5)
Missouri (142)
Montana (35)
Nebraska (28)
Nevada (132)
New Hampshire (80)
New Jersey (3177)
New Mexico (27)
New York (3121)
North Carolina (1494)
North Dakota (9)
Northern California (5479)
Ohio (339)
Oklahoma (21)
Oregon (43)
Pennsylvania (2327)
Puerto Rico (28)
Rhode Island (42)
South America (1096)
South Carolina (77)
South Dakota (1)
Southern California (4433)
Tennessee (183)
Texas (1868)
United States (40680)
Utah (357)
Vermont (1)
Virginia (299)
Washington D.C. (73)
Washington State (955)
West Virginia (3)
Wisconsin (120)
Wyoming (2)
638,397 Results for "medicines for malaria venture mmv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
April 15, 2026
·
8 min read
Press Releases
Novartis receives approval for first malaria medicine for newborn babies and young infants
July 8, 2025
·
8 min read
Press Releases
Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance
November 13, 2025
·
11 min read
Press Releases
Unitaid partners with USP to expand resilient production of essential medicines in Africa, for Africa
With local partners, the MedSuRe Africa project will foster sustainable, cost-competitive and quality production of medicines for malaria, HIV/AIDS, and maternal health
August 21, 2025
·
3 min read
Press Releases
Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria
January 8, 2026
·
4 min read
Press Releases
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
January 23, 2026
·
8 min read
Business
Novartis and MMV Move to Pivotal Study with New Class of Drug for Malaria
Novartis and Medicines for Malaria Venture are moving into Phase III for a combination treatment targeting the rise of artemisinin-resistant Malaria infection.
November 23, 2022
·
3 min read
·
Kate Goodwin
Press Releases
Attivare Therapeutics Awarded $6.6 Million Grant to Advance Durable Malaria Vaccine
December 15, 2025
·
2 min read
Hesperos Scientists Publish a New Study in Scientific Reports Titled: “Development of a Human Malaria-on-a-Chip Disease Model for Drug Efficacy and Off-Target Toxicity Evaluation”
A team of dedicated researchers at the human-on-a-chip company Hesperos, Inc. have taken on the challenge to investigate new ways to combat this disease in collaboration with the Medicines for Malaria Venture (MMV).
July 5, 2023
·
4 min read
Press Releases
MindBio Appoints Market Maker Venture Liquidity Providers
April 15, 2026
·
3 min read
1 of 63,840
Next
